Evidence map›Paper›PMID 30787611›Full record

ArticleInternational journal of nanomedicine2019

Establishing an osteoimmunomodulatory coating loaded with aspirin on the surface of titanium primed with phase-transited lysozyme.

Wenxin Zhang, Xin Lu, Zuoying Yuan, Minjuan Shen, Yunjia Song, Huanhuan Liu, Jingjing Deng, Xue Zhong, Xu Zhang

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Graphene Oxide: Preparation and Medical Research.Materials (Basel, Switzerland) · 2025
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Zn-Incorporated TiOInternational journal of nanomedicine · 2020
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Wenxin ZhangSchool of Dentistry, Stomatological Hospital, Tianjin Medical University, Tianjin, People's Republic of China, zhangxu@tmu.edu.cn.
Xin LuSchool of Dentistry, Stomatological Hospital, Tianjin Medical University, Tianjin, People's Republic of China, zhangxu@tmu.edu.cn.
Zuoying YuanState Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing, People's Republic of China.
Minjuan ShenSchool of Dentistry, Stomatological Hospital, Tianjin Medical University, Tianjin, People's Republic of China, zhangxu@tmu.edu.cn.
Yunjia SongSchool of Dentistry, Stomatological Hospital, Tianjin Medical University, Tianjin, People's Republic of China, zhangxu@tmu.edu.cn.
Huanhuan LiuSchool of Dentistry, Stomatological Hospital, Tianjin Medical University, Tianjin, People's Republic of China, zhangxu@tmu.edu.cn.
Jingjing DengSchool of Dentistry, Stomatological Hospital, Tianjin Medical University, Tianjin, People's Republic of China, zhangxu@tmu.edu.cn.
Xue ZhongSchool of Dentistry, Stomatological Hospital, Tianjin Medical University, Tianjin, People's Republic of China, zhangxu@tmu.edu.cn.
Xu ZhangSchool of Dentistry, Stomatological Hospital, Tianjin Medical University, Tianjin, People's Republic of China, zhangxu@tmu.edu.cn.
Tianjin Stomatological Hospital · CNTianjin Medical University · CNBeijing University of Chemical Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo improve osseointegration and enhance the success rate of implanted biomaterials, the surface modification technology of bone implants has developed rapidly. Intensive research on osteoimmunomodulation has shown that the surfaces of implants should possess favorable osteoimmunomodulation to facilitate osteogenesis.

methodsA novel, green and efficient phase-transited lysozyme (PTL) technique was used to prime titanium discs with a positive charge. In addition, sodium hyaluronate (HA) and self-assembled type I collagen containing aspirin (ASA) nanoparticles were decorated on PTL-primed Ti discs via electrostatic interaction.

resultsThe behaviors of bone marrow stromal cells (BMSCs) on the Ti disc surfaces containing ASA were analyzed in different conditioned media (CM) generated by macrophages. Additionally, the secretion of inflammation-related cytokines of macrophages on the surfaces of different Ti discs was investigated in in vitro experiments, which showed that the Ti surface containing ASA not only supported the migration, proliferation and differentiation of BMSCs but also reduced the inflammatory response of macrophages compared with Ti discs without surface modification. After implantation in vivo, the ASA-modified implant can significantly contribute to bone formation around the implant, which mirrors the evaluation in vitro.

conclusionThis study highlights the significant effects of appropriate surface characteristics on the regulation of osteogenesis and osteoimmunomodulation around an implant. Implant modification with ASA potentially provides superior strategies for the surface modification of biomaterials.

Indexed as

OsteogenesisPhase TransitionAnimalsAnti-Inflammatory AgentsAspirinCell AdhesionCell DifferentiationCell MovementCell ProliferationChitosanCoated Materials, BiocompatibleCulture Media, ConditionedDrug LiberationHumansHyaluronic AcidImmunologic FactorsAnti-Inflammatory AgentsAspirinChitosanCoated Materials, BiocompatibleCulture Media, ConditionedHyaluronic AcidImmunologic FactorsMuramidaseTitaniumnanoparticleosseointegrationosteoimmunomodulationtitanium surface modification

Identifiers

PMID30787611
PMCPMC6368129
OpenAlexW2913752544

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.